Investment reported as a low double-digit million EUR amount by CEO Manuel Zeller; investment made via Luxembourg-based Teseo Capital backed by the Ferrero family. Zero+ is a sugar replacement developed by Neoh (clinical study at Medical University of Vienna, 2022). Exact amount and valuations not disclosed; amount value here uses a rounded representative figure (10,000,000 EUR) based on 'low double-digit millions' description.